Dr. Elshoury is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8326 Naab Rd
Indianapolis, IN 46260Phone+1 317-871-0000Fax+1 317-871-0010
Education & Training
- Albany Medical CenterResidency, Internal Medicine, 2013 - 2016
- Ain Shams University Faculty of MedicineClass of 2007
Certifications & Licensure
- IN State Medical License 2024 - 2025
- NY State Medical License 2018 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Oral TP-3654 in Patients With Myelofibrosis Start of enrollment: 2019 Dec 16
Publications & Presentations
PubMed
- 1 citationsASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms.Hassan Awada, Manasa Bhatta, Han Yu, Wenyan Ji, Surui Hou
Leukemia. 2024-01-01 - Short-Term Storage of Mobilized Peripheral Blood Stem Cells in a Closed System Changes the Microenvironment and May Affect the Quantity of CD34Cells.and CD34CD38CD45RA...Amro Elshoury, Orla Maguire, Alexis Conway, Joseph Tario, Kah Teong Soh
Transplantation and Cellular Therapy. 2023-02-01 - 42 citationsMyeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.Aaron T Gerds, Jason Gotlib, Haris Ali, Prithviraj Bose, Andrew Dunbar
Journal of the National Comprehensive Cancer Network. 2022-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: